Compare two prostate biopsy guidance methods in men with PSA rise
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether using a “cognitive” approach versus a software-guided approach to plan a prostate biopsy is just as effective. It may help improve how biopsies are targeted for men with PSA changes and/or abnormal prostate exams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- Your PSA blood test has risen to 4–20 ng/mL, and/or your rectal exam was abnormal
- You agree to sign the informed consent form
- You do not have current or past prostatitis (prostate inflammation/infection)
- You are able to safely have a prostate biopsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to guide a prostate biopsy for men with abnormal MRI findings. It may help if you have never had a prostate biopsy and have certain PSA levels.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
This trial compares two ways to use MRI images during a prostate biopsy to see which finds cancer better. It looks at 'fusion' biopsy (where a computer combines MRI with live ultrasound) versus 'cognitive' biopsy (where the doctor mentally matches the MRI to the ultrasound).
This trial compares two ways to take a prostate biopsy (through the rectum or through the skin between the scrotum and anus) to see which is more accurate. Men with suspicious MRI findings (PI-RADS 3, 4, or 5) who haven't had prostate cancer before may be eligible.
This trial compares two types of biopsy methods (fusion-guided and cognitive-guided) for men with very small prostate lesions seen on MRI. It aims to see which method better detects early prostate cancer in these hard-to-find spots.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.